See Alzheimer’s Association Congress Proceedings, and
painmanagementusa.com
Wednesday, December 30, 2015
Alzheimer’s Agitation can be Helped
Agitation
in Alzheimer’s can now be helped by the drug combination of quinidine and
dextromethorphan. This complication can
be devastating for family members and nursing home personnel. However, even better results have been
reported by treating affected patients
with low level laser therapy around and
below the skull. The latter usually gets
great results in 5-10 treatments.
Occasional maintenance therapy might be needed. Memory problems are slower to respond, but
the loss of agitation shows the greatest improvement.
Tuesday, December 22, 2015
Cognitive Decline After Major Surgery
A
report at the Alzheimer’s Association Congress in Washington DC showed that at
least 20% of patients who undergo major surgery show significant cognitive
decline after the surgery. It makes
sense to me for such patients to receive a couple of vitamin C IVs prior to
surgery to reduce the risk and improve recovery followed by a phosphatidyl
choline and glutathione IV after surgery to preserve mental function. I have tried this and it works. The IVs are given in our office will not be
covered by Medicare, but they are not that expensive, and the consequences of
not taking this precaution might be major.
See Alzheimer’s Association
Congress Proceedings, Dr. Katie J. Schennings.
Thursday, December 17, 2015
Take Aspirin or Not?
Generally
speaking, aspirin is recommended after a patient has a heart attack and for
primary prevention of heart or stroke events for 87% of men and 16% of women,
ages 45-79 y.o. In real life, doctors
recommend aspirin on only 34% of men and in a robust 42% of women. This means the US Preventive Services is out
of touch with practicing physicians and their patients. One major probable reason is that aspirin can
cause brain hemorrhage and life-threatening gastric ulcers. I usually suggest a more gentle route of
nattokinase, garlic, vitamin E, EDTA, or other more natural combination to
reduce the risk and avoid the side effects.
See US Preventive Services Task Force, latest issue.
Tuesday, December 15, 2015
Dramatic Increases in the Cost of Drugs and Nutrients
In both the
Senate and House of Representatives, there have been recent inquiries about
drug companies that buy the rights to produce critical drugs and then greatly increase
the price. Turing Pharmaceuticals
recently increased the price of Daraprim, which is the only drug approved for
severe toxoplasmosis infections, by 5000%.
Complementary physicians can treat many diseases with high dose IV
nutrients such as vitamins C and B-complex.
However, nutrient supply companies are also gouging the public. Vitamin C for IV treatment recently jumped up
from $13 to $65 with no explanation. It
might be a good time to send a note of concern to our elected officials.
See Associated Press article for Nov. 5, 2015.
Thursday, December 10, 2015
The Other “Drug Problem”
A
JAMA article showed that the number of US adults who take prescription drugs increased
from 51% to 59% from 1999 to 2012. The
prevalence of those taking 5 or more drugs almost doubled during the same
timeframe, from 8% to 15%. Large increases
were noted for drugs to treat cholesterol, depression, acid reflux, and muscle
spasms. The effect was irrespective of
age. Please listen carefully to all the
side effects mentioned in the TV advertisements for drugs.
Tuesday, December 8, 2015
Metformin Can Increase Neuropathy
Metformin
is a very commonly prescribed drug for Diabetes, polycystic ovaries, and even
has been touted as an anti-aging therapy.
However, a Swedish study has found that metformin can cause a vitamin
B12 deficiency, which in turn has been linked to peripheral neuropathies. If you are taking metformin, you should be
tested for B12. If you already have a
neuropathy a trial of B12 injections might be beneficial.
See Family Practice News, October 15, p. 3.
Thursday, December 3, 2015
Chelation is Much More Effective than New Drug to Prevent CV Death for Diabetics
The new
drug, empaliflozin, reduces the risk for future cardiac events, including
premature death by 14% when added to conventional care. This was in the front-page article of Family
Practice News in October. However, the
TACT study of chelation produced a reduction of the same end points by about
50%. Chelation also reduces the toxic
metal load for patients, which might lessen the risk of cancer and other
diseases. If you are a diabetic, or even
a pre-diabetic, I urge you to consider chelation. Without chelation, having diabetes shortens
the lifespan by 5-7 years. Nothing works
better.
See Family Practice News, October 15, 2015, p. 1.
Tuesday, December 1, 2015
The FDA IS Going After Arthritic Patients and Their Docs?
See The Pulse of Natural Health, April 28, 2015.
Subscribe to:
Posts (Atom)